Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
Abstract:
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and an agent that decreases or inhibits TIGIT expression and/or activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
Information query
Patent Agency Ranking
0/0